Drospirenone and Estradiol Articles

Mixed views on drospirenone OCs

9 December 2011

Schering AG commits to operating margin of 16% this year and 18% in 2006

4 July 2005

Schering AG sees 1st-qtr net profit rise 11%, with strong sales growth in USA

25 April 2005

Schering AG's Angeliq on track in USA

20 September 2004

Schering AG's Angeliq launched in Europe

6 September 2004

Schering AG's R&D day impressive, but doubts over short term, say analysts

7 July 2003

Update: Sales up 11% at Schering AG

10 March 2003

Prempro fall-out could affect Schering AG

22 July 2002

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end